Key insights
- Avantor appointed Gerard Porreca as EVP, Quality and Regulatory. Recent earnings exceeded expectations, with EPS at $0.17 versus $0.16 forecast, and revenue at $1.581B versus $1.54B expected. RBC Capital initiated coverage with a Sector Perform rating and a $9.00 price target. These factors suggest a slightly positive outlook for the stock.
RADNOR, Pa. - Avantor Inc. (NYSE:AVTR) announced today that Gerard Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Porreca will lead quality assurance, quality systems and regulatory affairs globally across all of Avantor’s businesses, according to a press release statement. The company provides products and services to customers in the life sciences and advanced technology industries.
Porreca previously worked at Getinge, where he led the Quality and Regulatory organization through global product approvals and regulatory engagement across the U.S., EU MDR, and China. Before Getinge, he held senior executive positions at Becton Dickinson and Company, C.R. Bard Inc., and Smith+Nephew plc.
"Jerry’s deep expertise in global quality systems and complex regulatory landscapes will be vital as we continue to enhance and scale our operations and deliver mission critical solutions for our customers," said Emmanuel Ligner, Avantor’s President and CEO.
Porreca stated that quality and regulatory excellence represent a key value proposition for customers in the life sciences and advanced technology sectors.
Avantor’s portfolio is used in research, development and production activities at more than 300,000 customer locations in 180 countries.
In other recent news, Avantor Inc. reported its financial results for the first quarter of 2026, exceeding analyst expectations. The company achieved an earnings per share (EPS) of $0.17, surpassing the forecasted $0.16. Revenue also outperformed projections, reaching $1.581 billion compared to the anticipated $1.54 billion. Additionally, RBC Capital initiated coverage on Avantor with a Sector Perform rating and set a price target of $9.00. The firm expressed a positive view of the management’s turnaround efforts while acknowledging the execution challenges that remain. These recent developments provide investors with a clearer picture of Avantor’s current financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.